ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
复制标题
DOI:
10.1016/j.rmed.2021.106638
复制
发表时间:
2021-11
影响因子:
4.3
通讯作者:
Signes-Costa J
中科院分区:
文献类型:
--
作者:
Ferrer S;Sancho J;Bocigas I;Bures E;Mora H;Monclou E;Mulet A;Quezada A;Royo P;Signes-Costa J
High-Flow Nasal Cannula (HFNC) therapy is useful treatment in patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate) has been evaluated to predict success of HFNC in patients with pneumonia. The aim of this study was to determine whether the ROX Index could predict HFNC therapy success in patients with ARF due to SARS-CoV-2 pneumonia. An observational, prospective study was performed including patients admitted with ARF secondary to SARS-CoV-2 pneumonia who met criteria for HFNC therapy initiation. Demographic, radiological, laboratory and clinical course data were collected. The ROX index was calculated at 1 h, 6 h, 12 h and 24 h after starting HFNC. In total 85 patients were included (age, 64.51 + 11.78 years; male, 69.4%). HFNC failed in 47 (55.3%) patients, of whom 45 (97.8%) were initially managed with noninvasive ventilation (NIV). ROX index at 24 h was the best predictor of HFNC success (AUC 0.826, 95%CI 0.593–1.00, p = 0.015) with a cut-off point of 5.35 (S 0.91, Sp 0.79, PPV 0.92, NPP 0.79). In multivariate logistic regression analysis ROX index at 24 h proved the best predictor of HFNC success. ROX index at 24 h with a cut-off point of 5.35 predicts HFNC success in patients with SARS-Cov-2-induced ARF.
登录
查看更多内容
影响因子:
2.3
作者:
Panadero C;Abad-Fernández A;Rio-Ramirez MT;Acosta Gutierrez CM;Calderon-Alcala M;Lopez-Riolobos C;Matesanz-Lopez C;Garcia-Prieto F;Diaz-Garcia JM;Raboso-Moreno B;Vasquez-Gambasica Z;Andres-Ruzafa P;Garcia-Satue JL;Calero-Pardo S;Sagastizabal B;Bautista D;Campos A;González M;Grande L;Jimenez Fernandez M;Santiago-Ruiz JL;Caravaca Perez P;Alcaraz AJ
通讯作者:
Alcaraz AJ
影响因子:
3.7
作者:
Prakash J;Bhattacharya PK;Yadav AK;Kumar A;Tudu LC;Prasad K
通讯作者:
Prasad K
影响因子:
15.8
作者:
通讯作者:
--
DOI:
10.15557/pimr.2020.0003
发表时间:
2020-01-01
影响因子:
3.6
作者:
通讯作者:
--
影响因子:
2.5
作者:
Chandel, Abhimanyu;Patolia, Saloni;King, Christopher S.
通讯作者:
King, Christopher S.